Clinical Approach to Uterine Disease

  • Enrico Sartori
  • Daniela Gatti
  • Federico Quaglia


A fibroid (also known as fibroma, myoma, fibromyoma and leiomyoma) is a benign tumor of the uterus which arises from the smooth muscle cells of the myometrium. The estimated incidence between 15% and 30% is almost certainly conservative, with a peak between 35 and 50 years.


Endometrial Carcinoma Uterine Fibroid Female Reproductive System Pelvic Wall Nostic Factor 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American College of Obstetricians and Gynecologists (1994) Uterine leiomyomata. ACOG Technical Bulletin 192, Washington, DCGoogle Scholar
  2. American Fertility Society (1992) Myomas and reproductive dysfunction: guideline for practice. The American Fertility Society, Birmingham, ALGoogle Scholar
  3. Buttram VC Jr, Reiter RC (1981) Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36:433–445PubMedGoogle Scholar
  4. Quade BJ (1995) Pathology, cytogenetics, and molecular biology of uterine leiomyomas and other smooth muscle lesions. Curr Opin Obstet Gynecol 7:35–42CrossRefPubMedGoogle Scholar
  5. Vollenhoven BJ, Lawrence AS, Healy DL (1990) Uterine fibroids: a clinical review. Br J Obstet Gynaecol 97:285–298PubMedGoogle Scholar
  6. Ayhan A, Tuncer R, Tuncer ZS et al (1994) Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases). Int J Gynecol Cancer 4:306–309CrossRefPubMedGoogle Scholar
  7. Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60:2035–2041CrossRefPubMedGoogle Scholar
  8. Frei KA, Kinkel K (2001) Staging endometrial cancer: role of magnetic resonance imaging. J Magn Reson Imaging 13:850–855CrossRefPubMedGoogle Scholar
  9. Mariani A, Maurice JW, Keeney GL et al (2003) Endometrial cancer: predictors of peritoneal failure. Gynecol Oncol 89:236–242CrossRefPubMedGoogle Scholar
  10. Sartori E, Gadducci A, Landoni F et al (2001) Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int J Gynecol Cancer 11:430–437CrossRefPubMedGoogle Scholar
  11. Trimble EL, Kosary C, Park RC (1998) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71:340–343CrossRefPubMedGoogle Scholar
  12. Wilson TO, Podtraz KC, Gaffey TA et al (1990) Evaluation of unfavourable histologic subtypes in endometrial adenocarcinoma. Am J Obset Gynecol 162:418–426Google Scholar
  13. Zaino RJ, Kurman RJ, Diana KL, Morrow CP (1996) Pathologic models to predict outcome for women with endometrial adenocarcinoma: the importance of the distinction between surgical stage and clinical stage. A Gynecologic Oncology Group Study. Cancer 77:1115–1121CrossRefPubMedGoogle Scholar
  14. Magrina JF, Goodrich MA, Lidner TK et al (1999) Modified radical hysterectomy in the treatment of early squamous cervical cancer. Gynecol Oncol 72:183–186CrossRefPubMedGoogle Scholar
  15. Markman M (2007) HPV vaccines to prevent cervical cancer. Lancet 369:1837–1839CrossRefPubMedGoogle Scholar
  16. Mathur SP, Mathur RS, Creasman WT et al (2005) Early non invasive diagnosis of cervical cancer. Cancer Biomark 1:183–191PubMedGoogle Scholar
  17. Rose PG, Bundy BN, Watkins EB et al (1999) Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Eng J Med 340:1144–1153CrossRefGoogle Scholar
  18. Zand KR, Reinhold C, Abe H et al (2007) Magnetic resonance imaging of the cervix. Cancer Imaging 7:769–776CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Enrico Sartori
    • 1
  • Daniela Gatti
    • 1
  • Federico Quaglia
    • 1
  1. 1.Department of Gynaecology and ObstetricsUniversity of Brescia A. O. Spedali CiviliBresciaItaly

Personalised recommendations